Anti-PDCD1/PD-1/CD279 Antibody (Budigalimab)
Catalog No.
F1323
Anti-PDCD1/PD-1/CD279 Antibody (Budigalimab)
Featured Products
Budigalimab (ABBV 181; PR 1648817) is a humanIgG1 Monoclonal antibody targeting programmed cell death 1 (PD-1) receptors. Budigalimab has an Fc mutation that reduces Fc receptor interactions and inhibition of effector factors.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.76 kDa
Dry ice
2098225-93-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ABBV-181, PR-1648817
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.